Andreas Norlin

Technik-/Wissenschafts-/F&E-Leiter bei ASCELIA PHARMA AB

Vermögen: 12 367 $ am 31.05.2024

54 Jahre

Health Technology

Consumer Services

Technology Services

Aktive Positionen von Andreas Norlin

Unternehmen	Position	Beginn	Ende
ASCELIA PHARMA AB	Technik-/Wissenschafts-/F&E-Leiter	01.01.2020	-
ApoGlyx AB ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden.	Direktor/Vorstandsmitglied	-	-
Desupervised ApS Desupervised ApS Information Technology ServicesTechnology Services Part of Hamiltonian Holding ApS, Desupervised ApS is a Danish company that provides artificial intelligence software services. The company is based in Copenhagen, Denmark.	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
Xkout Bioscience AB	Gründer	-	-

University of Lund

Doctorate Degree

International

Schweden	5
Dänemark	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ASCELIA PHARMA AB	Health Technology

Private Unternehmen	3
ApoGlyx AB ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden.	Health Technology
Xkout Bioscience AB
Desupervised ApS Desupervised ApS Information Technology ServicesTechnology Services Part of Hamiltonian Holding ApS, Desupervised ApS is a Danish company that provides artificial intelligence software services. The company is based in Copenhagen, Denmark.	Technology Services